Moldova Pharmaceutical Market Q1-Q3 2025: Value Rises 5.5%, Volume Rises 4.6%
Moldova pharmaceutical market grew 5.5% in value in the first nine months of 2025, reaching €204.39 million, with a 4.6% increase in volume. The latest…
A Manufacturer’s Guide: 3 Costly “Last Mile” Mistakes to Avoid in Your 2026 Moldova Pharma Launch
Planning a Moldova pharma launch? Avoid these 3 costly “last mile” mistakes. Learn how integrated distribution & our pharmacy network drive pharma sales…
Moldova’s Oncology Procurement 2026: A $6.1 Million Invitation and Untapped Opportunities for Global Pharma
Moldova’s 2026 oncology procurement has confirmed contracts worth over $6.1M, signaling major investment in innovative cancer therapies. This analysis details…
Moldova Pharmaceutical Market H1 2025: Value Rises 8.27% Amid Volume Dip
Moldova pharmaceutical market grew 8.27% in value in the first six months of 2025, reaching €136.55 million, despite a 2.88% dip in volume. The latest…
A Manufacturer’s Guide to Moldova’s Pharma Market: 2025 Regulations & Statistics
As the Republic of Moldova progresses on its journey as an EU candidate, Moldova’s pharma market presents a significant and evolving opportunity for foreign…